Pricing & Availability
- Clone
- 104 (See other available formats)
- Regulatory Status
- RUO
- Other Names
- Ly-5.2, LCA
- Isotype
- Mouse (SJL) IgG2a, κ
- Ave. Rating
- Submit a Review
- Product Citations
- publications

-

C57BL/6 mouse splenocytes stained with 104 FITC
Compare all formats See FITC spectral data
| Cat # | Size | Price | Quantity Check Availability | Save | ||
|---|---|---|---|---|---|---|
| 109805 | 50 µg | $45.00 | ||||
| 109806 | 500 µg | $105.00 | ||||
CD45.2 is an alloantigen of CD45, expressed by Ly5.2 bearing mouse strains (e.g., A, AKR, BALB/c, CBA/Ca, CBA/J, C3H/He, C57BL, C57BR, C57L, C58, DBA/1, DBA/2, NZB, SWR, 129). CD45, a member of the protein tyrosine phosphatase (PTP) family, is a 180-240 kD glycoprotein expressed on all hematopoietic cells except mature erythrocytes and platelets. There are multiple isoforms in the mouse that play key roles in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation states of the cell as well as specific cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.
Product Details
Technical data sheet
Product Details
- Reactivity
- Mouse
- Antibody Type
- Monoclonal
- Host Species
- Mouse
- Immunogen
- B10.S mouse thymocytes and splenocytes
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
- Preparation
- The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
- Concentration
- 0.5 mg/ml
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC – Quality tested
- Recommended Usage
-
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis6 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.
- Excitation Laser
- Blue Laser (488 nm)
- Application Notes
-
The 104 antibody does not react with mouse cells expressing the CD45.1 alloantigen. Additional reported applications (for the relevant formats) include: immunoprecipitation4, in vivo and in vitro blocking of B cell responses1,2, and immunohistochemical staining of acetone-fixed frozen sections3.
- Application References
(PubMed link indicates BioLegend citation)
-
- Yakura H, et al. 1983. J. Exp. Med. 157:1077. (Block)
- Yakura H, et al. 1986. J. Immunol. 136:2729. (Block)
- Suzuki K, et al. 2000. Immunity 13:691. (IHC)
- Shen FW, et al. 1986. Immunogenetics 24:146. (IP)
- Baldwin TA and Hogquist KA. 2007. J. Immunol. 179:837.
- Pascal V, et al. 2007. J. Immunol. 179:1751.
- Burman AC, et al. 2007. Blood 110:1064.
- Kincaid EZ, et al. 2007. J. Immunol. 179:3187.
- Phan TG, et al. 2007. Nature Immunol. 8:992.
- Nakano-Yokomizo T, et al. 2011. J. Exp Med. 208:1661. PubMed
- Wen T, et al. 2013. PNAS. 110:6067. PubMed
- Kohlmeier JE, et al. 2008. Immunity. 29:101. (FC) PubMed
- Product Citations
-
- Ma W, et al. 2017. Cell Death & Disease. 10.1038/cddis.2017.47. PubMed
- Platteel A, et al. 2017. Vaccine.. 10.1016/j.vaccine.2017.10.044. PubMed
- Hsieh WC, et al. 2018. Nat Commun. 9:463. PubMed
- Emgård J, et al. 2018. Immunity. 143:419. PubMed
- Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
- Kleppe M et al. 2018. Cancer cell. 33(1):29-43 . PubMed
- Landon J Edgar et al. 2018. Cell chemical biology. 26(1):131-136 . PubMed
- Malik A et al. 2018. Immunity. 49(3):515-530 . PubMed
- Sade–Feldman M, et al. 2018. Cell. 175:998. PubMed
- Bing Wu et al. 2018. Immunity. 49(5):886-898 . PubMed
- Zhu YP et al. 2018. Cell reports. 24(9):2329-2341 . PubMed
- Stewart I et al. 2018. Immunity. 49(3):477-489 . PubMed
- Kang YH, et al. 2019. Nat Commun. 10:912. PubMed
- Uchil PD et al. 2018. Cell host & microbe. 25(1):87-100 . PubMed
- Abbott RK, et al. 2018. Immunity. 48:133. PubMed
- Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
- Bijalwan M, et al. 2019. Sci Rep. 9:3444. PubMed
- Sultan H, et al. 2018. Cancer Immunol Res. 6:617. PubMed
- Wang H, et al. 2019. Nat Commun. 10:1898. PubMed
- Halvarsson C, et al. 2019. Antioxid Redox Signal. 31:211. PubMed
- Radulovic V, et al. 2020. Cell Reports. 27(10):2826-2836.e5.. PubMed
- Swidergall M, et al. 2019. Cell Rep. 28:423. PubMed
- Bhattacharjee S, et al. 2019. Cell Rep. 28:231. PubMed
- Hung LY, et al. 2019. J Immunol. 203:511. PubMed
- Koyama M et al. 2019. Immunity. 51(5):885-898 . PubMed
- Nelson CE et al. 2019. Cell Rep. 28(12):3092-3104 . PubMed
- Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
- Kaplan BLF et al. 2018. Current protocols in toxicology. 75:11:00 25. PubMed
- Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
- Gundra UM, et al. 2017. Nat Immunol. 1.195833333. PubMed
- Wan X, et al. 2018. Nature. 560:107. PubMed
- Schulz A, et al. 2019. Cell Rep. 29:1074. PubMed
- Field CS, et al. 2020. Cell Metab. 31:422. PubMed
- Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
- Williams JB, et al. 2020. Nat Commun. 0.876388889. PubMed
- Stifter SA, et al. 2019. Cell Rep. 29:3539. PubMed
- Morelli AE, et al. 2020. Cell Rep. 30:3448. PubMed
- de Laval B, et al. 2020. Cell Stem Cell. 26(5):657-674. PubMed
- Zhang J, et al. 2019. Exp Hematol. 78:21:00. PubMed
- Guiducci E, et al. 2018. Front Immunol. 1.467361111. PubMed
- Burman A, et al. 2007. Blood. 110:1064. PubMed
- Michalova J, et al. 2011. Biol Blood Marrow Transplant. 17:1273. PubMed
- MacDonald K, et al. 2014. J Immunol. 192:3180. PubMed
- Stienstra R, et al. 2014. Diabetes. 63:4143. PubMed
- Burgess M, et al. 2014. Blood. 124:3947. PubMed
- Leon-Rico D, et al. 2015. Lab Anim. 49:132. PubMed
- Koyama M, et al. 2015. J Exp Med. 212: 1303 – 1321. PubMed
- Andresen L, et al. 2016. PLoS One. 11: 0148428. PubMed
- Bosma M, et al. 2016. Nat Commun. 7: 11314. PubMed
- Jaako P, et al. 2016. Leukemia. 10.1038/leu.2016.159. PubMed
- Tan X, et al. 2016. PLoS One. 11: 0160985. PubMed
- Swanson P, et al. 2016. PLoS Pathog. 12:e1006022. PubMed
- Atkin-Smith G, et al. 2017. Sci Rep. 7:39846. PubMed
- Peter Morawski, Chen-Feng Qi, Silvia Boll 2017. Sci Rep. 7:40838. PubMed
- Huang D, et al. 2020. Nat Commun. 4.520833333. PubMed
- Corrado M, et al. 2020. Cell Metab. 32:981. PubMed
- Li J, et al. 2020. Elife. 9:00. PubMed
- Kesavardhana S, et al. 2020. J Biol Chem. 295:8325. PubMed
- Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
- Acharya N, et al. 2020. Immunity. 53(3):658-671.e6. PubMed
- Wu B, et al. 2021. Immunity. 54(2):308-323.e6. PubMed
- Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
- Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
- RRID
- AB_313442 (BioLegend Cat. No. 109805)
AB_313443 (BioLegend Cat. No. 109806)
Antigen Details
- Structure
- Protein tyrosine phosphatase (PTP) family, 180-240 kD
- Distribution
-
All hematopoietic cells except mature erythrocytes and platelets of the CD45.2 strain of mice
- Function
- Phosphatase, T and B cell activation
- Ligand/Receptor
- Galectin-1, CD2, CD3, CD4
- Biology Area
- Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers
- Molecular Family
- CD Molecules
- Antigen References
-
1. Suzuki K, et al. 2000. Immunity 13:691.
- Gene ID
- 19264 View all products for this Gene ID
- UniProt
- View information about CD45.2 on UniProt.org
Related Products
| Description | Clone | Applications |
|---|
Related FAQs
There are no FAQs for this product.
Other Formats
View All CD45.2 Reagents Request Custom Conjugation
| Description | Clone | Applications |
|---|---|---|
| Biotin anti-mouse CD45.2 | 104 | FC |
| FITC anti-mouse CD45.2 | 104 | FC |
| PE anti-mouse CD45.2 | 104 | FC |
| Purified anti-mouse CD45.2 | 104 | FC, Block, IHC-F, IP |
| APC anti-mouse CD45.2 | 104 | FC |
| Alexa Fluor® 488 anti-mouse CD45.2 | 104 | FC |
| Alexa Fluor® 647 anti-mouse CD45.2 | 104 | FC |
| Pacific Blue™ anti-mouse CD45.2 | 104 | FC |
| Alexa Fluor® 700 anti-mouse CD45.2 | 104 | FC |
| APC/Cyanine7 anti-mouse CD45.2 | 104 | FC |
| PerCP anti-mouse CD45.2 | 104 | FC |
| PerCP/Cyanine5.5 anti-mouse CD45.2 | 104 | FC |
| PE/Cyanine7 anti-mouse CD45.2 | 104 | FC |
| Brilliant Violet 421™ anti-mouse CD45.2 | 104 | FC |
| Brilliant Violet 570™ anti-mouse CD45.2 | 104 | FC |
| Brilliant Violet 650™ anti-mouse CD45.2 | 104 | FC |
| Brilliant Violet 510™ anti-mouse CD45.2 | 104 | FC |
| Brilliant Violet 785™ anti-mouse CD45.2 | 104 | FC |
| Brilliant Violet 605™ anti-mouse CD45.2 | 104 | FC |
| Purified anti-mouse CD45.2 (Maxpar® Ready) | 104 | FC, CyTOF® |
| PE/Dazzle™ 594 anti-mouse CD45.2 | 104 | FC |
| Brilliant Violet 711™ anti-mouse CD45.2 | 104 | FC |
| Alexa Fluor® 594 anti-mouse CD45.2 | 104 | IHC-F |
| APC/Fire™ 750 anti-mouse CD45.2 | 104 | FC |
| TotalSeq™-A0157 anti-mouse CD45.2 | 104 | PG |
| TotalSeq™-B0157 anti-mouse CD45.2 | 104 | PG |
| TotalSeq™-C0157 anti-mouse CD45.2 | 104 | PG |
| Brilliant Violet 750™ anti-mouse CD45.2 | 104 | FC |
| Spark Blue™ 550 anti-mouse CD45.2 | 104 | FC |
| Spark NIR™ 685 anti-mouse CD45.2 | 104 | FC |